Drug profile · INN
miglitol
MIGLITOL
miglitol (MIGLITOL) is a lysosomal alpha-glucosidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — miglitol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
miglitol (MIGLITOL) is a lysosomal alpha-glucosidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Lysosomal alpha-glucosidase inhibitor
Primary target: Lysosomal alpha-glucosidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is miglitol?
miglitol (MIGLITOL) is a lysosomal alpha-glucosidase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for miglitol?
MIGLITOL is a marketed brand name for miglitol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of miglitol?
miglitol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.